Mio Yamamoto Selected Research

Mio Yamamoto Research Topics

1	Non-alcoholic Fatty Liver Disease 01/2022
1	Liver Diseases (Liver Disease) 06/2020
1	Constipation 05/2019
1	Obesity 01/2016
1	Orthostatic Hypotension (Postural Hypotension) 09/2015
1	Genetic Translocation (Chromosomal Translocation) 08/2011
1	Subcutaneous panniculitis-like T-cell lymphoma 01/2011
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 01/2011
1	Disseminated Intravascular Coagulation 01/2011
1	Neoplasms (Cancer) 01/2011
1	Multiple Myeloma 11/2010
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 07/2010
1	Leukemia 04/2010
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2008
1	Philadelphia Chromosome 12/2008

1	FructoseIBA 01/2022
1	LipidsIBA 01/2022
1	AntioxidantsIBA 01/2022
1	Sucrose (Saccharose)IBA 01/2022
1	Transaminases (Aminotransferases)IBA 01/2022
1	PolyphenolsIBA 01/2022
1	CytokinesIBA 01/2022
1	Inulin FDA Link 05/2019
1	SaltsIBA 01/2016
1	hydroxide ionIBA 09/2015
1	Messenger RNA (mRNA)IBA 08/2011
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2011
1	purineIBA 01/2011
1	Alkylating AgentsIBA 01/2011
1	Cytotoxins (Cytolysins)IBA 01/2011
1	Dacarbazine (DIC)FDA LinkGeneric 01/2011
1	Methylprednisolone FDA LinkGeneric 01/2011
1	Bortezomib (Velcade)FDA Link 11/2010
1	Tyrosine Kinase InhibitorsIBA 07/2010
1	Activating Transcription Factor 3IBA 07/2010
1	Dasatinib (BMS 354825)FDA Link 04/2010
1	fludarabineIBA 04/2010
1	HLA Antigens (Human Leukocyte Antigens)IBA 12/2008

3	Therapeutics 06/2020 - 04/2010
1	Drug Therapy (Chemotherapy) 01/2011
1	Transplantation 11/2010
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 04/2010